J&J Q2 skin care sales
This article was originally published in The Rose Sheet
Executive Summary
Strong growth of Neutrogena outside the U.S. and strength of Clean & Clear and Aveeno in all markets drive 10.8% growth in second quarter skin care sales, Johnson & Johnson reports during presentation to analysts July 16. Global skin care sales in the period reached $400 mil., while U.S. skin care sales rose 10.2% to $206 mil., according to the company. Worldwide Consumer segment sales, including the skin care, baby care, McNeil and women's health businesses, grew 7.8% to $1.65 bil. in Q2, with U.S. sales up 12.4% to $907 mil., the firm reports in a 1July 16 release...